Sun Pharma gets nod from South African regulator for generic semaglutide injection
The approval by the SAHPRA is to manufacture and market the generic version of semaglutide injection in South Africa for the treatment of adults with inadequately controlled type 2 diabetes mellitus…
Read the full article2d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.